Chemotherapy intensification in patients with advanced seminoma and adverse prognostic factors.

about

Chemotherapy intensification in patients with advanced seminoma and adverse prognostic factors.

Item

http://www.wikidata.org/entity/Q41585249

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Chemotherapy intensification i ...... nd adverse prognostic factors.

@en

type

Item

label

Chemotherapy intensification i ...... nd adverse prognostic factors.

@en

prefLabel

Chemotherapy intensification i ...... nd adverse prognostic factors.

@en

P1476

Chemotherapy intensification i ...... nd adverse prognostic factors.

@en

P2093

Alexandra Tjulandina

http://www.w3.org/2001/XMLSchema#string

Alexey Tryakin

http://www.w3.org/2001/XMLSchema#string

Anatoly Bulanov

http://www.w3.org/2001/XMLSchema#string

Anna Vybarava

http://www.w3.org/2001/XMLSchema#string

August Garin

http://www.w3.org/2001/XMLSchema#string

Dzhennet Chekini

http://www.w3.org/2001/XMLSchema#string

Konstantin Figurin

http://www.w3.org/2001/XMLSchema#string

Mikhail Fedyanin

http://www.w3.org/2001/XMLSchema#string

Olga Sekhina

http://www.w3.org/2001/XMLSchema#string

Sergei Tjulandin

http://www.w3.org/2001/XMLSchema#string

P2860

A risk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: results of the GETUG S99 multicenter prospective study.

European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II.

Prognostic factors in seminomas with special respect to HCG: results of a prospective multicenter study. Seminoma Study Group.

Advanced seminoma--treatment results and prognostic factors for survival after first-line, cisplatin-based chemotherapy and for patients with recurrent disease: a single-institution experience in 145 patients.

Prognostic impact of LDH levels in patients with relapsed/refractory seminoma.

P2888

s00432-015-1914-5

P304

1259-1264

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00432-015-1914-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

141

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25586890

http://www.w3.org/2001/XMLSchema#string